Senior Scientist
Johnson & Johnson
Andrew Zhou, B.S. is a 4th year PhD candidate in the Department of Pharmaceutics at the University of Minnesota-Twin Cities. His current research interests involve the identification of molecular mechanisms driving BBB dysfunction in Alzheimer's disease and metabolic syndrome. After graduation, he intends to transition into a preclinical PK/PD group in the pharmaceutical industry with a focus on biologics development, preferably for neuroscience indications.